{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:35:17Z","timestamp":1778646917936,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bbrc.2013.12.041","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T15:50:40Z","timestamp":1386863440000},"page":"761-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of protein synthesis and JNK activation are not required for cell death induced by anisomycin and anisomycin analogues"],"prefix":"10.1016","volume":"443","author":[{"given":"David","family":"Monaghan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enda","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye L.","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis J.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison N.","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard O.","family":"Fearnhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bbrc.2013.12.041_b0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clon.2011.03.013","article-title":"Metastatic triple-negative breast cancer","volume":"23","author":"Rakha","year":"2011","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"5","key":"10.1016\/j.bbrc.2013.12.041_b0010","doi-asserted-by":"crossref","first-page":"120066","DOI":"10.1098\/rsob.120066","article-title":"Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?","volume":"2","author":"Borst","year":"2012","journal-title":"Open Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2013.12.041_b0015","first-page":"389","article-title":"Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin","volume":"4","author":"Mechetner","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrc.2013.12.041_b0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/clpt.2011.14","article-title":"Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development","volume":"89","author":"Moitra","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bbrc.2013.12.041_b0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm.2090","article-title":"Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer","volume":"16","author":"Li","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2013.12.041_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-4741.2011.01175.x","article-title":"The paradox of triple negative breast cancer: novel approaches to treatment","volume":"18","author":"Fornier","year":"2012","journal-title":"Breast J."},{"issue":"11","key":"10.1016\/j.bbrc.2013.12.041_b0035","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.onc.1204235","article-title":"Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance","volume":"20","author":"Turton","year":"2001","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbrc.2013.12.041_b0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nrd1900","article-title":"Finding new tricks for old drugs: an efficient route for public-sector drug discovery","volume":"4","author":"O\u2019Connor","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7154","key":"10.1016\/j.bbrc.2013.12.041_b0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbrc.2013.12.041_b0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0022-2836(74)90119-3","article-title":"(3H)anisomycin binding to eukaryotic ribosomes","volume":"84","author":"Barbacid","year":"1974","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.bbrc.2013.12.041_b0055","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/MCB.17.6.3373","article-title":"Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin\/ricin loop in the 28S rRNA","volume":"17","author":"Iordanov","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2013.12.041_b0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/toxsci\/kfi146","article-title":"Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck","volume":"85","author":"Zhou","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"14","key":"10.1016\/j.bbrc.2013.12.041_b0065","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1158\/0008-5472.CAN-09-0778","article-title":"Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse","volume":"69","author":"Liu","year":"2009","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.bbrc.2013.12.041_b0070","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1158\/0008-5472.CAN-07-1687","article-title":"A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis","volume":"67","author":"Mawji","year":"2007","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bbrc.2013.12.041_b0075","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6600612","article-title":"Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis","volume":"87","author":"Curtin","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"23","key":"10.1016\/j.bbrc.2013.12.041_b0080","doi-asserted-by":"crossref","first-page":"20593","DOI":"10.1074\/jbc.M211010200","article-title":"Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase","volume":"278","author":"Sah","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2013.12.041_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1039\/b311242j","article-title":"Synthetic anisomycin analogues activating the JNK\/SAPK1 and p38\/SAPK2 pathways","volume":"2","author":"Rosser","year":"2004","journal-title":"Org. Biomol. Chem."},{"issue":"10","key":"10.1016\/j.bbrc.2013.12.041_b0090","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s10495-009-0386-y","article-title":"TPCK-induced apoptosis and labelling of the largest subunit of RNA polymerase II in Jurkat cells","volume":"14","author":"Fabian","year":"2009","journal-title":"Apoptosis"},{"issue":"Pt 22","key":"10.1016\/j.bbrc.2013.12.041_b0095","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1242\/jcs.024547","article-title":"A non-apoptotic role for caspase-9 in muscle differentiation","volume":"121","author":"Murray","year":"2008","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.bbrc.2013.12.041_b0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nmeth.1314","article-title":"SUnSET, a nonradioactive method to monitor protein synthesis","volume":"6","author":"Schmidt","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbrc.2013.12.041_b0175","series-title":"Non-Parametric Statistics for the Behavioural Sciences","author":"Siegal","year":"1956"},{"issue":"5","key":"10.1016\/j.bbrc.2013.12.041_b0110","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/bc070085u","article-title":"Biotinylated anisomycin: a comparison of classical and \u201cclick\u201d chemistry approaches","volume":"18","author":"Inverarity","year":"2007","journal-title":"Bioconjug. Chem."},{"issue":"39","key":"10.1016\/j.bbrc.2013.12.041_b0115","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"Hirschmann-Jax","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbrc.2013.12.041_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2011.10.001","article-title":"In vivo toxicological evaluation of anisomycin","volume":"208","author":"Tang","year":"2012","journal-title":"Toxicol. Lett."},{"issue":"11","key":"10.1016\/j.bbrc.2013.12.041_b0125","doi-asserted-by":"crossref","first-page":"e27988","DOI":"10.1371\/journal.pone.0027988","article-title":"Identification of cytotoxic drugs that selectively target tumor cells with MYC overexpression","volume":"6","author":"Frenzel","year":"2011","journal-title":"PLoS ONE"},{"issue":"28","key":"10.1016\/j.bbrc.2013.12.041_b0130","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1016\/j.febslet.2005.10.025","article-title":"Ha-Ras sensitizes transformed mouse skin cells to anisomycin-induced apoptosis","volume":"579","author":"Santibanez","year":"2005","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.bbrc.2013.12.041_b0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.nlm.2008.02.007","article-title":"Time course and efficiency of protein synthesis inhibition following intracerebral and systemic anisomycin treatment","volume":"90","author":"Wanisch","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"issue":"8","key":"10.1016\/j.bbrc.2013.12.041_b0140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/1541-7786.MCR-06-0433","article-title":"Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim","volume":"5","author":"Xia","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbrc.2013.12.041_b0145","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1073\/pnas.95.11.6015","article-title":"Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP","volume":"95","author":"Sanna","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"27","key":"10.1016\/j.bbrc.2013.12.041_b0150","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1074\/jbc.272.27.16725","article-title":"Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2","volume":"272","author":"Park","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bbrc.2013.12.041_b0155","first-page":"2576","article-title":"Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation","volume":"60","author":"Ruth","year":"2000","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrc.2013.12.041_b0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0022-2836(03)00668-5","article-title":"Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit","volume":"330","author":"Hansen","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"23","key":"10.1016\/j.bbrc.2013.12.041_b0165","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1073\/pnas.81.23.7637","article-title":"Requirement for protein synthesis in the regulation of a circadian rhythm by serotonin","volume":"81","author":"Eskin","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbrc.2013.12.041_b0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/clpt.2012.240","article-title":"Intracellular drug concentrations","volume":"93","author":"Dollery","year":"2013","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13021001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13021001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T02:56:40Z","timestamp":1538967400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13021001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0006291X13021001"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.041","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of protein synthesis and JNK activation are not required for cell death induced by anisomycin and anisomycin analogues","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}